Clinical Trial

Right Ventricular Function Changes After CIED Implantation: The RIGHT-CIED Study

Study acronym: RIGHT-CIED
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to understand how the right side of the heart changes in people who receive an implantable cardiac electronic device (CIED), such as a pacemaker, ICD, or CRT device. The right ventricle (RV) can sometimes be affected after these devices are placed, but the reasons and timing are not well understood. To investigate this, we will examine participants at two time-points: before their device is implanted and again six months later. At each visit, we will assess heart function using echocardiography, a non-contrast cardiac MRI scan, and an ultrasound score of venous congestion called the VEXUS score. We will also take a small blood sample to measure a biomarker called FGF-23, which may reflect changes in heart function. The study does not involve any experimental treatment, and all implanted devices are part of routine medical care. The imaging tests and blood samples are for research purposes only. By comparing the measurements before and after device implantation, we hope to better understand how CIEDs influence right-sided heart function and whether imaging findings are related to changes in blood biomarkers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-27.
Trial Details
NCT Number NCT07272395
Lead Sponsor Istanbul University - Cerrahpasa
Conditions Right Ventricular Dysfunction
Enrollment 40 participants
Start Date 2025-08-15
Primary Completion 2026-10-21 (estimated)
Study Completion 2026-11-25 (estimated)
Updated on ClinicalTrials.gov 2025-12-16